SAN DIEGO, Dec. 11, 2023 /PRNewswire/ -- Notable Labs, ("Notable") (Nasdaq: NTBL), a clinical stage therapeutic platform company developing predictive precision medicines for cancer patients, today ...
TURKU, FI / ACCESS Newswire / March 27, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) New analysis and biomarker data strengthens understanding of bexmarilimab's potential TURKU, FINLAND - Faron ...
The Myelodysplastic Syndromes (MDS) Foundation supports the positive opinion from the European Union's Committee for Medicinal Products for Human Use (CHMP) recommending approval of VIDAZA ...
A new molecular scoring system promises to improve the treatment of a set of blood cancers called myelodysplastic syndromes (MDS), according to an international team of researchers. The findings were ...
FOSTER CITY, Calif., July 13, 2020 (GLOBE NEWSWIRE) -- Notable, which is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers, announced today ...
FOSTER CITY, Calif., April 30, 2020 (GLOBE NEWSWIRE) -- Notable, which is redefining cancer treatment with its scientific technology platform to rapidly advance drug development, announced a ...
An expert discussed the findings of the COMMANDS trial evaluating Reblozyl’s role in red blood cell transfusion independence for patients with MDS. Reblozyl (luspatercept) has become the new standard ...
The Aplastic Anemia & MDS International Foundation presented its first Lifetime Achievement in Science Award to Mary Horowitz, MD, MS at the Foundation’s 35th Anniversary Luncheon and Awards Program ...
The FDA approved ivosidenib for treatment of certain adults with relapsed or refractory myelodysplastic syndromes. The indication applies to use of the agent in adults who harbor susceptible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results